Osaic Holdings’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-83
| Closed | -$3.9K | – | 8162 |
|
|
2025
Q3 | $3.9K | Sell |
83
-2,183
| -96% | -$103K | ﹤0.01% | 6885 |
|
|
2025
Q2 | $101K | Buy |
2,266
+2,005
| +768% | +$89.2K | ﹤0.01% | 4501 |
|
|
2025
Q1 | $11.5K | Sell |
261
-1,282
| -83% | -$59K | ﹤0.01% | 5713 |
|
|
2024
Q4 | $46.6K | Buy |
1,543
+284
| +23% | +$9.92K | ﹤0.01% | 4762 |
|
|
2024
Q3 | $40.3K | Sell |
1,259
-199
| -14% | -$7.43K | ﹤0.01% | 4897 |
|
|
2024
Q2 | $54.9K | Sell |
1,458
-33
| -2% | -$1.39K | ﹤0.01% | 4609 |
|
|
2024
Q1 | $73.4K | Sell |
1,491
-1,371
| -48% | -$63.4K | ﹤0.01% | 4468 |
|
|
2023
Q4 | $104K | Sell |
2,862
-698
| -20% | -$18.2K | ﹤0.01% | 4416 |
|
|
2023
Q3 | $82.3K | Buy |
3,560
+951
| +36% | +$26K | ﹤0.01% | 4650 |
|
|
2023
Q2 | $68.5K | Buy |
2,609
+782
| +43% | +$20.5K | ﹤0.01% | 4733 |
|
|
2023
Q1 | $47K | Sell |
1,827
-54
| -3% | -$1.58K | ﹤0.01% | 4996 |
|
|
2022
Q4 | $49K | Sell |
1,881
-182
| -9% | -$4.48K | ﹤0.01% | 4947 |
|
|
2022
Q3 | $58K | Buy |
2,063
+576
| +39% | +$16.5K | ﹤0.01% | 4794 |
|
|
2022
Q2 | $36K | Sell |
1,487
-51
| -3% | -$1.86K | ﹤0.01% | 5200 |
|
|
2022
Q1 | $86K | Sell |
1,538
-2
| -0.1% | -$114 | ﹤0.01% | 4707 |
|
|
2021
Q4 | $95K | Buy |
1,540
+745
| +94% | +$49.3K | ﹤0.01% | 4638 |
|
|
2021
Q3 | $51K | Buy |
795
+541
| +213% | +$41.7K | ﹤0.01% | 5089 |
|
|
2021
Q2 | $21K | Hold |
254
| – | – | ﹤0.01% | 5630 |
|
|
2021
Q1 | $19K | Buy |
+254
| New | +$19.9K | ﹤0.01% | 5521 |
|
Other funds holding SWTX
Osaic Holdings's SWTX Position: Q4 2025 in Review
Osaic Holdings sold out of SpringWorks Therapeutics (SWTX) in Q4 2025, closing a stake of 83 shares — an estimated $3.9K sold.
Osaic Holdings first reported a position in SWTX in Q1 2021 and held it in 19 quarters. The position peaked at $104K in Q4 2023. 2 funds tracked by Wall St. Rank hold SWTX as of Q4 2025.
- Osaic Holdings reported no remaining SpringWorks Therapeutics position as of Q4 2025 after selling out during the quarter.
- Osaic Holdings sold 83 SpringWorks Therapeutics shares in Q4 2025, an estimated $3.9K.
- Osaic Holdings first reported a position in SpringWorks Therapeutics in Q1 2021 and held it in 19 quarters.
- Osaic Holdings's SpringWorks Therapeutics position peaked at $104K in Q4 2023.
- 2 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q4 2025.
Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.